Luther King Capital Management (LKCM)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $6.68M | Hold |
|
|||||
|
2023
Q1 | $5.96M | Hold |
|
|||||
|
2022
Q4 | $2.49M | Hold |
|
|||||
|
2022
Q3 | $1.65M | Hold |
|
|||||
|
2022
Q2 | $1.99M | Sell |
|
|||||
|
2022
Q1 | $2.25M | Sell |
|
|||||
|
2021
Q4 | $2.07M | Sell |
|
|||||
|
2021
Q3 | $11.6M | Buy |
|
|||||
|
2021
Q2 | $15.8M | Buy |
|
|||||
|
2021
Q1 | $11.1M | Buy |
|
|||||
|
2020
Q4 | $12.2M | Buy |
|
|||||
|
2020
Q3 | $8.42M | Buy |
|
|||||
|
2020
Q2 | $12.8M | Buy |
|
|||||
|
2020
Q1 | $9.41M | Hold |
|
|||||
|
2019
Q4 | $13.3M | Sell |
|
|||||
|
2019
Q3 | $8.58M | Buy |
|
|||||
|
2019
Q2 | $9.39M | Buy |
|
|||||
|
2019
Q1 | $8.46M | Hold |
|
|||||
|
2018
Q4 | $5.55M | Buy |
|
|||||
|
2018
Q3 | $7.65M | Hold |
|
|||||
|
2018
Q2 | $3.27M | Buy |
|
|||||
|
2018
Q1 | $1.3M | Buy |
|
|||||
|
2017
Q4 | $1.63M | Hold |
|
|||||
|
2017
Q3 | $1.79M | Buy |
|
|||||
|
2017
Q2 | $1.77M | Hold |
|
|||||
|
2017
Q1 | $1.27M | Buy |
|